8q24 risk alleles in West African and Caribbean men

Prostate

Volumn 72, Issue 12, 2012, Pages 1366-1373

  Murphy, Adam B ^a   Ukoli, Flora ^b   Freeman, Vincent ^c   Bennett, Frankly ^d   Aiken, William ^d   Tulloch, Trevor ^d   Coard, Kathleen ^d   Angwafo, Fru ^e   Kittles, Rick A ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

^e UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

8q24; Caribbean; genetic risk; prostate cancer; West Africans

Indexed keywords

AGED; ALLELE; ARTICLE; CAMEROON; CANCER EPIDEMIOLOGY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAMAICA; MAJOR CLINICAL STUDY; MALE; NIGERIA; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; CAMEROON; CARIBBEAN REGION; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; ETHNIC GROUPS; GENETIC ASSOCIATION STUDIES; HUMANS; JAMAICA; MALE; MIDDLE AGED; NIGERIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84864290453     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22486     Document Type: Article

References (44)

1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K,. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38 (6): 652-658. (Pubitemid 43927306)
2. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D,. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39 (5): 638-644. (Pubitemid 46676106)
3. Li L, Plummer SJ, Thompson CL, Merkulova A, Acheson LS, Tucker TC, Casey G,. A common 8q24 variant and the risk of colon cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17 (2): 339-342. (Pubitemid 351272784)
4. Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S, Siegmund KD, Casey G, Thibodeau SN, Jenkins MA, Hopper JL, Byrnes GB, Baron JA, Goode EL, Tiirikainen M, Lindor N, Grove J, Newcomb P, Jass J, Young J, Potter JD, Haile RW, Duggan DJ, Le Marchand L,. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: Results from the Colon Cancer Family Registry. Cancer Res 2007; 67 (23): 11128-11132. (Pubitemid 350248536)
5. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, Ahaghotu C, Kittles R, Carpten J,. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007; 17 (12): 1717-1722. (Pubitemid 351359995)
6. Witte JS,. Multiple prostate cancer risk variants on 8q24. Nat Genet 2007; 39 (5): 579-580. (Pubitemid 46676095)
7. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G,. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39 (5): 645-649. (Pubitemid 46676108)
8. Yeager M, Xiao N, Hayes RB, Bouffard P, Desany B, Burdett L, Orr N, Matthews C, Qi L, Crenshaw A, Markovic Z, Fredrikson KM, Jacobs KB, Amundadottir L, Jarvie TP, Hunter DJ, Hoover R, Thomas G, Harkins TT, Chanock SJ,. Comprehensive resequence analysis of a 136kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet 2008; 124 (2): 161-170.
9. Bock CH, Schwartz AG, Ruterbusch JJ, Levin AM, Neslund-Dudas C, Land SJ, Wenzlaff AS, Reich D, McKeigue P, Chen W, Heath EI, Powell IJ, Kittles RA, Rybicki BA,. Results from a prostate cancer admixture mapping study in African-American men. Hum Genet 2009; 126 (5): 637-642.
10. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, Eeles R, Hsing AW, Chanock S, Hu JJ, John EM, Park J, Stefflova K, Zeigler-Johnson C, Rebbeck TR,. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev 2011; 20 (1): 23-32.
11. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D,. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006; 103 (38): 14068-14073. (Pubitemid 44452981)
12. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, Yamamura Y, Neslund-Dudas C, Thun MJ, Murphy A, Casey G, Sheng X, Wan P, Pooler LC, Monroe KR, Waters KM, Le Marchand L, Kolonel LN, Stram DO, Henderson BE,. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet 2011; 7 (5): e1001387.
13. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, Zeigler-Johnson C, Yamamura Y, Neslund-Dudas C, Haslag-Minoff J, Wu W, Thomas V, Allen GO, Murphy A, Chang BL, Zheng SL, Leske MC, Wu SY, Ray AM, Hennis AJ, Thun MJ, Carpten J, Casey G, Carter EN, Duarte ER, Xia LY, Sheng X, Wan P, Pooler LC, Cheng I, Monroe KR, Schumacher F, Le Marchand L, Kolonel LN, Chanock SJ, Berg DV, Stram DO, Henderson BE,. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 2011; 43 (6): 570-573.
14. Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C, Carpten J, Kittles RA,. Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate 2010; 70 (3): 270-275.
15. Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB,. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007; 99 (20): 1525-1533. (Pubitemid 351767236)
16. Whittemore AS, Keller JB, Betensky R,. Low-grade, latent prostate cancer volume: Predictor of clinical cancer incidence? J Natl Cancer Inst 1991; 83 (17): 1231-1235.
17. Society AC. Cancer facts & figures for African Americans 2007-2008. Atlanta: American Cancer Society; 2007.
18. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y,. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer 2008; 123 (2): 430-435. (Pubitemid 351842030)
19. Delongchamps NB, Singh A, Haas GP,. Epidemiology of prostate cancer in Africa: Another step in the understanding of the disease? Curr Probl Cancer 2007; 31 (3): 226-236. (Pubitemid 46818421)
20. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N,. Prostate cancer disparities in Black men of African descent: A comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 2009; 4 (Suppl 1) S2.
21. Akinremi TO, Ogo CN, Olutunde AO,. Review of prostate cancer research in Nigeria. Infect Agent Cancer 2011; 6 (Suppl 2): S8.
22. Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM,. CYP3A4-V and prostate cancer in African Americans: Causal or confounding association because of population stratification? Hum Genet 2002; 110 (6): 553-560. (Pubitemid 36075004)
23. Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA,. COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis 2004; 25 (6): 961-966. (Pubitemid 38886082)
24. Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, Ali A, Ravindranath L, Dobi A, Sesterhenn IA, McLeod DG, Srivastava S, Freedman M, Petrovics G,. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiol Biomarkers Prev 2010; 19 (1): 1-8.
25. Ukoli F, Osime U, Akereyeni F, Okunzuwa O, Kittles R, Adams-Campbell L,. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol 2003; 10 (6): 315-322. (Pubitemid 36776075)
26. Angwafo FF III, Zaher A, Befidi-Mengue R, Wonkam A, Takougang I, Powell I, Murphy G,. High-grade intra-epithelial neoplasia and prostate cancer in Dibombari. Cameroon. Prostate Cancer Prostatic Dis 2003; 6 (1): 34-38. (Pubitemid 36437483)
27. Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W, Ahaghotu C, Kittles RA,. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. Prostate Cancer Prostatic Dis 2006; 9 (3): 284-292. (Pubitemid 44317264)
28. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, Adams-Campbell L, Dunston GM,. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: Implications for prostate cancer risk. Hum Genet 2001; 109 (3): 253-261. (Pubitemid 32926918)
29. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H,. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358 (9): 910-919. (Pubitemid 351397090)
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC,. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 2007; 81 (3): 559-575. (Pubitemid 47330214)
31. Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR,. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology 2003; 61 (5): 987-992. (Pubitemid 36547744)
32. Benn-Torres J, Bonilla C, Robbins CM, Waterman L, Moses TY, Hernandez W, Santos ER, Bennett F, Aiken W, Tullock T, Coard K, Hennis A, Wu S, Nemesure B, Leske MC, Freeman V, Carpten J, Kittles RA,. Admixture and population stratification in African Caribbean populations. Ann Hum Genet 2008; 72 (Pt 1): 90-98.
33. Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL,. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate 2009; 69 (4): 363-372.
34. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K,. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39 (5): 631-637. (Pubitemid 46676102)
35. Benford ML, VanCleave TT, Lavender NA, Kittles RA, Kidd LR,. 8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study. BMC Cancer 2010; 10: 334.
36. Ishak MB, Giri VN,. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies. Cancer Epidemiol Biomarkers Prev 2011; 20 (8): 1599-1610.
37. Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM,. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: The Flint Men's Health Study. Prostate 2011; 71 (3): 225-231.
38. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL, Isaacs WB,. Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 2009; 18 (7): 2145-2149.
39. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Kaaks R, Key T, Kolonel LN, Kraft P, Le Marchand L, Ma J, Pike MC, Riboli E, Stampfer MJ, Stram DO, Thomas G, Thun MJ, Travis R, Virtamo J, Andriole G, Gelmann E, Willett WC, Hunter DJ,. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007; 67 (7): 2951-2956. (Pubitemid 46724830)
40. Severi G, Hayes VM, Padilla EJ, English DR, Southey MC, Sutherland RL, Hopper JL, Giles GG,. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: Results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007; 16 (3): 610-612. (Pubitemid 46548668)
41. Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA,. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007; 16 (4): 809-814. (Pubitemid 46650586)
42. Wang L, McDonnell SK, Slusser JP, Hebbring SJ, Cunningham JM, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN,. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007; 67 (7): 2944-2950. (Pubitemid 46724829)
43. Potts PR, Yu H,. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol Cell Biol 2005; 25 (16): 7021-7032. (Pubitemid 41105901)
44. Okobia MN, Zmuda JM, Ferrell RE, Patrick AL, Bunker CH,. Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry. Prostate 2011; 71 (10): 1054-1063.